SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-14-131888
Filing Date
2014-04-04
Accepted
2014-04-04 16:56:53
Documents
1
Group Members
BC ADVISORS, LLCBECKER DRAPKIN PARTNERS (QP), L.P.BECKER DRAPKIN PARTNERS, L.P.MATTHEW A. DRAPKINSTEVEN R. BECKER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDEMENT NO. 7 d706538dsc13da.htm SC 13D/A 125973
  Complete submission text file 0001193125-14-131888.txt   127776
Mailing Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033
Business Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033 (323) 224-3900
RESPONSE GENETICS INC (Subject) CIK: 0001124608 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83739 | Film No.: 14746591
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 500 CRESCENT COURT SUITE 230 DALLAS TX 75201
Business Address 500 CRESCENT COURT SUITE 230 DALLAS TX 75201 (214) 756-6016
Becker Drapkin Management, L.P. (Filed by) CIK: 0001346543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A